Silica nanoparticles functionalized with beta-cyclodextrin (CD) host molecules (5) have been prepared by reacting carboxylic active ester-terminated silica nanoparticles (4) with CD heptamine. Silica nanoparticles functionalized with glucosamine (6), having similar surface properties as 5 but lacking the host-guest recognition motif, were used to perform blank experiments. The CD-functionalized silica nanoparticles 5 were determined by TEM to be 55 +/- 6 nm in size. They exhibited pH-dependent aggregation, which is explained by the presence of free amino and carboxylic acid groups on the particle surface, which was corroborated by zeta potential measurements. The functionalization with CD was further confirmed by host-guest studies in solution and at CD-functionalized silicon substrates. The addition of an adamantyl-terminated dendrimer, capable of multivalent host-guest binding with CD, led to strong aggregation of the CD particles 5, but not of the glucosamine-functionalized 6. Furthermore, 5 gave strong adsorption to CD monolayers on silicon onto which adamantyl-terminated dendrimers were adsorbed, whereas 6 did not. The good discrimination between dendrimer-covered and uncovered areas of the CD monolayer substrates allowed the directed self-assembly of the silica particles 5 onto dendrimer-patterned areas created by microcontact printing.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/la047982w | DOI Listing |
Curr Cancer Drug Targets
January 2025
Department of Clinical Laboratory, Gongli Hospital of Shanghai Pudong New Area, Shanghai, 200135, China.
Background: Lenvatinib is an oral tyrosine kinase inhibitor that selectively inhib-its receptors involved in tumor angiogenesis and tumor growth. It is an emerging first-line treatment agent for hepatocellular carcinoma (HCC). However, there is no intravenous ad-ministration of Lenvatinib.
View Article and Find Full Text PDFNanoscale
January 2025
Department of Biomedical Engineering, Sogang University, Seoul 04107, Korea.
The differentiation of human induced pluripotent stem cells (hiPSCs) into neural progenitor cells (NPCs) is a promising approach for the treatment of neurodegenerative diseases and regenerative medicine. Dual-SMAD inhibition using small molecules has been identified as a key strategy for directing the differentiation of hiPSCs into NPCs by regulating specific cell signaling pathways. However, conventional culture methods are time-consuming and exhibit low differentiation efficiency in neural differentiation.
View Article and Find Full Text PDFJ Pharm Sci
January 2025
Nanotech Laboratory, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER) Guwahati, Changsari, Kamrup 781101, Assam, India. Electronic address:
The application of mesoporous silica nanoparticles (MSN) as a drug carrier system got immense attention in the past few years due to their exceptional high drug loading efficiency. However, the process of drug loading is quite challenging compared to other lipid-based drug delivery systems. Hence, the MSNs using different catalysts were synthesized, and their mesoporous material characteristic was confirmed by the type IV adsorption-desorption isotherm using BET analyzer.
View Article and Find Full Text PDFNanotechnol Sci Appl
January 2025
Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, Indonesia.
Purpose: Improving drug solubility is crucial in formulating poorly water-soluble drugs, especially for oral administration. The incorporation of drugs into mesoporous silica nanoparticles (MSN) is widely used in the pharmaceutical industry to improve physical stability and solubility. Therefore, this study aimed to elucidate the mechanism of poorly water-soluble drugs within MSN, as well as evaluate the impact on the dissolution and physical stability.
View Article and Find Full Text PDFACS Med Chem Lett
January 2025
Key Laboratory of Biomedical Functional Materials, School of Science, China Pharmaceutical University, Nanjing 211198, China.
In this study, hollow mesoporous silica nanoparticles (HMSN) coated with a 4T1 tumor cell membrane were used to construct biomimetic nanomaterials (DTX@CHMSN) for the treatment of breast cancer. The nanodrug can improve the water solubility of polyenetaxel (DTX) by taking advantage of the special structure, good biocompatibility, and adjustable surface chemical properties of HMSN. Hollow mesoporous silica nanoparticles are coated with 4T1 cell membranes derived from homologous tumors (CHMSN).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!